#Electra Therapeutics

IPO 📈 Stocks

ADARx Targets $1.74 Billion Valuation in Upcoming Nasdaq IPO

September 21, 2026 (50 days ago)

ADARx Pharmaceuticals eyes a $1.74 billion valuation as it joins a wave of biotech listings, supported by a strategic $100 million investment…

ADRX ABBV Electra Therapeutics +1

🌍 US Read More →

News 📈 Stocks

Biotech IPO Market Faces Scrutiny as 8 Firms Seek Capital for Clinical Trials

September 18, 2026 (52 days ago)

Investors are prioritizing clinical-stage biotechs with proven potential, as eight companies navigate the IPO process with varying degrees of market readiness and…

Grifols Electra Therapeutics Tarsier Therapeutics +6

🌍 GLOBAL Read More →